Top Abstract Purchase Related
Home
>
Node
>
Subnode

Effect of estracyt on the rat prostate

Yamanaka, H.; Shimazaki, J.; Imai, K.; Sugiyama, Y.; Shida, K.

Investigative Urology 14(5): 400-404

1977

ISSN/ISBN: 0021-0005
PMID: 845006
Document Number: 110942
Two types of experiments were performed to elucidate the estrogenic effect of estracyt on the ventral and immature rats that had received injections of testosterone; then changes in weight of accessory rats and changes in weight of the total body, the ventral and the dorsolateral prostates, and adrenal gland, and changes in activities of testosterone 5alpha-reductase, alkaline phosphatase, and arginase of both lobes of the prostates were examined. In the second experiment, estracyt was injected into castrates rats and immature rats that had received injections of testosterone; then changes in weight of accessory sex organs were determined. Because similar changes were induced by treatment of animals with estradiol-17beta, it was concluded that the effect of estracyt on the prostates was most likely attributable to the estrogenic effect of the drug.

Document emailed within 1 workday
Secure & encrypted payments

Bouffioux, C.; de Leval, J. 1980: Estracyt, new therapeutic agent for cancer of the prostate Revue Medicale de Liege 35(24): 865-870
Wadström, J.; Huber, P.R.; Scholer, A.; Rutishauser, G. 1984: Effect of prostate massage on the levels of prostate acid phosphatase in the serum and urine Helvetica Chirurgica Acta 51(3-4): 437-440
Vaidya, H.C.; Wolf, B.A.; Garrett, N.; Catalona, W.J.; Clayman, R.V.; Nahm, M.H. 1988: Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the "hook effect" Clinical Chemistry 34(10): 2175-2177
Koda, A.; Hiramatsu, M.; Yoshida, Y. 1974: Pharmacological study of prostate extract (III). Critric acid content and aconitase and isocitrate dehydrogenase activities in normal and hypertrophic prostates and the effect of prostate extracts Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(5): 603-608
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Nilsson, T. 1980: Estracyt--clinical experiences Scandinavian Journal of Urology and Nephrology. Supplementum 55: 135-138
Nilsson, T. 1980: Clinical experience with Estracyt Acta Urologica Belgica 48(1): 133-137
Helsingborg/Lundbeck, L. 1975: Drug information. Estramustini phophas (Estracyt) Ugeskrift for Laeger 137(38): 2203-2204
Jönsson, G. 1971: Continued experiences with Estracyt in the treatment of advanced prostatic cancer Nordisk Medicin 85(6): 186-187
Yamanaka, H.; Shida, K. 1984: Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt" Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 537-544
Hata, M. 1988: Stage D1 prostatic cancer benefited by a single regimen of Estracyt Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(5): 1787-1790
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Nishio, S.; Kishimoto, T.; Maekawa, M.; Kawakita, J.; Hayahara, N.; Yuki, K.; Morikawa, Y.; Yasumoto, R.; Kato, Y.; Funai, K. 1986: Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1763-1770
Forshell, G.P.; Müntzing, J.; Ek, A.; Lindstedt, E.; Dencker, H. 1976: The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer Investigative Urology 14(2): 128-131
Gustafson, A.; Persson, B.; Tisell, L.E.; Wiklund, O.; Ohlson, R. 1977: Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism Investigative Urology 15(3): 220-224
Kumar, N.; Vasudeva, P.; Kumar, A.; Singh, H.; Sinha, A. 2015: A prospective comparative study of channel photoselective vaporization of prostate vs. channel transurethral resection of prostate in patients with advanced carcinoma prostate Minerva Urologica e Nefrologica 2015
Kumar, N.; Vasudeva, P.; Kumar, A.; Singh, H.; Sinha, A. 2016: A prospective comparative study of channel photoselective vaporization of the prostate vs. channel transurethral resection of the prostate in patients with advanced prostate carcinoma Minerva Urologica e Nefrologica 68(4): 330-336
Nixon, R.G.; Lilly, J.D.; Liedtke, R.J.; Batjer, J.D. 1997: Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen Archives of Pathology and Laboratory Medicine 121(4): 385-391
Kravchenko, L.S.; Oksman, A.I.; Konstantinova, I.M.; Tereshin, I.M. 1979: Effect of levorin on the chromatin of the prostate of dogs in its hypertrophy Antibiotiki 24(3): 212-217